13F filing recap · Q4 2024

What did AKO Capital buy in Q4 2024?

Reported stock-position changes between this filing and the previous one.

Stock value

$7.24B

Positions

Estimated turnover

12.0%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

Quarter in review

AKO Capital opened new positions in Illumina and Booz Allen Hamilton. The firm trimmed Visa, Alcon, and Microsoft slightly, while adding to Accenture, Copart, Procter & Gamble, and Equifax. It substantially reduced Warner Music Group and Linde, and made moderate cuts to Intercontinental Exchange, Fair Isaac, and Thermo Fisher Scientific.

New positions

ILMNIllumina, Inc.$66.19Mreported value+495.3K shares BAHBooz Allen Hamilton Holding Corporation$11.90Mreported value+92.5K shares

Increased positions

ACNAccenture Plc$461.36Mreported value+136.2K shares+11.6%GEGeneral Electric Company$449.18Mreported value+44.8K shares+1.7%MRSHMarsh & Mclennan Companies, Inc.$438.17Mreported value+89.6K shares+4.5%INTUIntuit Inc.$373.63Mreported value+45.6K shares

Reduced positions

VVisa Inc.$555.33Mreported value-33.6K shares-1.9%ALCAlcon Inc.$498.58Mreported value-281.5K shares-4.6%MSFTMicrosoft Corporation$481.66Mreported value-122.5K shares-9.7%ICEIntercontinental Exchange, Inc.$388.27Mreported value-373.9K shares